← Leaderboards
Karl Rickels
University Of Pennsylvania
$2,115,451
Attributed
$2,115,451
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $459.1K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$2,115,451 · 1
By mechanism
R01$2,115,451 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Irwin Lucki$12,636,171
- Ira R Katz$8,268,803
- Paul F Crits-Christoph$12,594,443
- Hank F Kung$16,346,808
- Scott A Mackler$3,917,409
Others in their field
Top investigators on “Venlafaxine”
- Charles F Reynolds · University Of Pittsburgh At Pittsburgh$6,574,013
- Irene H Richard · University Of Rochester$3,673,391
- Richard W Foltin · Columbia University Health Sciences$3,570,903
- David A. Brent · University Of Pittsburgh At Pittsburgh$3,307,100
- Jacques P Barber · University Of Pennsylvania$3,258,052
- Edward V Nunes · Columbia University Health Sciences$3,007,365
Research focus
VenlafaxineAnxiety DisordersDistressAntidepressive AgentsAnxietyAcuteBuspironeConditionCaringChronicChronic DiseaseClassBenzodiazepinesAlppAnti-Anxiety AgentsControlled StudyCostDependenceDepressed MoodDepressive SymptomsDiagnosisDisease RemissionDisease /Therapy DurationAgonist
Grant awards (5)
Short-Term vs Long-Term Treatment for GAD$434,603
R01 · FY2008 · MH · contact PI
Short-Term vs Long-Term Treatment for GAD$441,982
R01 · FY2007 · MH · contact PI
Short-Term vs Long-Term Treatment for GAD$459,097
R01 · FY2006 · MH · contact PI
Short-Term vs Long-Term Treatment for GAD$401,726
R01 · FY2005 · MH
Short-Term vs Long-Term Treatment for GAD$378,043
R01 · FY2004 · MH